Valens Semiconductor Ltd. Q3 2025 Earnings Recap

VLN Q3 2025 November 12, 2025

Valens Semiconductor reported a strong Q3 2025, exceeding revenue guidance with $17.3 million driven by robust demand in the ProEV market, marking the sixth consecutive quarter of growth.

Earnings Per Share Beat

$-0.04 vs $-0.07 est.

+42.9% surprise

Revenue Miss

17335000 vs 18775000 est.

-7.7% surprise

Market Reaction

1-Day +1.18%

5-Day -14.71%

30-Day -9.41%

Key Takeaways

Revenue of $17.3 million surpassed guidance of $15.1–$15.6 million, with expectations for Q4 2025 revenue to range between $18.2–$18.9 million.
GAAP gross margin reached 63%, outperforming projections, while adjusted EBITDA loss was $4.3 million.
Significant product traction noted for VF3000 and VA7000 chipsets, positioning Valens for strong growth in ProEV and medical sectors.
Successful launch of V7000-based disposable endoscopies highlights innovation in medical technology, catering to emerging trends in minimally invasive procedures.
Leadership transition to Johann Stalinger as CEO effective tomorrow, signifying a strategic shift in executive management stability.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit VLN on AllInvestView.